Compare Ginkgo Bioworks Holdings Inc (DNA) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Eli Lilly And Co — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Eli Lilly And Co trades at $1,213 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 2135.5× Ginkgo Bioworks Holdings Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | LLY | |
|---|---|---|
Market Cap | $505.73M | $1.08T |
Sector | Health | Health |
52-Week High | $16.14 | $1.24K |
52-Week Low | $5.48 | $639.43 |
Enterprise Value | $607.68M | $1.13T |
Dividend Yield | — | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
